The chemical production area is dedicated to providing active ingredients for pharmaceuticals on time, at reasonable cost and in the necessary quality, for existing and new products. This is done in compliance with the applicable GMP (Good Manufacturing Practice), safety and environmental standards. The production plants at Ingelheim are particularly concerned with the manufacturing of new and innovative substances. The production of active ingredients involves several operations, including initial manufacture, interim and end-stage production. The production facilities comprise high-tech, multipurpose plants, which are operated under stringent GMP and safety conditions. Active ingredients are also extracted from plant materials, which are purified before use. Ingelheim is also home to the centre of excellence for crushing technology. Ancillary functions to support the production areas include hydrogenation, supply of solvents to all chemical plants and exhaust air purification.

The purpose of this section is to provide innovative and efficient infrastructural services. Global Real Estate Management, for instance, has both a governance and a service function for all real estate transactions within the Boehringer Ingelheim group. This section is responsible for selling and buying real estate at minimal risk and under financially advantageous conditions, for renting space as required and administering sale-and-lease-back or built-to-suit projects. Engineering and Site Services also provides competitive logistics solutions, ranging from standardised to innovative solutions that add value for all stakeholders. Our employees undergo continuous professional development to offer our customers high-quality, low-cost services. Adhering to the principle of "Green Logistics", we aim to strike a balance between ecological and economic aspects and to incorporate new and alternative technologies from the logistics and transport sectors. Site Engineering and Technology is also responsible for energy supplies, provision of services (cleaning, maintenance, grounds maintenance, reception, hospitality etc.) and space management.

Quality Management is a key function in all industries but especially so in the pharmaceutical industry, which is required to comply with national, European and international laws, guidelines and standards as well as specific quality requirements agreed under the terms of approvals from destination countries. With 1,000 staff, the Quality department works closely with the chemical and pharmaceutical production, engineering and supply chain management departments to assure the quality of Boehringer Ingelheim active substances, pharmaceuticals and Inhalation Devices destined for more than 100 countries. The Quality department is based in offices and laboratory facilities at Ingelheim, Biberach and Dortmund where materials and products undergo chemical, physical and microbiological tests, using a wide range of modern equipment. Techniques include High Pressure Liquid Chromatography, Gas Chromatography, Mass Spectroscopy and a number of special analyses, for example to determine particle size distributions in inhalation drugs The Quality department is therefore looking for technicians with a background in chemical, biological or pharmaceutical laboratory work or who have a natural science degree in pharmacy, chemistry or biology. Experience and expertise in Quality Assurance is also desirable. Because the department has a global purview, good English language skills are required.

The main tasks of Engineering and Technology are process and plant engineering. The teams in process engineering are responsible for ensuring the efficient execution of investment projects while considering economic aspects. But they also give safety-related support to production units in Germany. Since Boehringer Ingelheim is a global company with international production sites, international engineering support in a global engineering network is also necessary. Plant engineers on the other hand are operators of all supply facilities.

We at Boehringer Ingelheim realise that developing and producing high quality medicine is not enough; we have to be able to effectively get these products to the patient too. For this reason, we focus heavily on creating a comprehensive supply chain management system that relies on transparency and innovative processes to realise our organisational strategy. This means employing the most modern, cost-effective technologies to get the most from our high production and engineering capacity in order to guarantee our ability to compete on a global scale. The primary goal is to create a centralised provision of needs-oriented and reliable services in order to introduce and supply our products to the market in the best way possible. Furthermore, we structure our supply chain with our strategic vision in mind: from raw material to finished product, everything is planned for. Transparency is very important in this regard, and we provide all necessary information to our internal process partners. For us, success means integrating our suppliers, resulting in competitive production through the most efficient processes, shortest throughput times, and lowest costs.

The qualification profile is divided among several fields including a variety of medical professionals, mathematicians, statistical programmers, and medical documentation specialists, to name but a few. The field has an international focus: English is the working language in medicine

Boehringer Ingelheim’s sales force is the company’s direct link with clients. Members of this highly qualified team implement the strategies and concepts developed by the marketing department in their discussions and interactions with healthcare providers. The core of Boehringer Ingelheim’s sales communications is scientific information about our innovative products, disease management and health outcomes. We offer a range of customised event concepts that respond to client needs in a targeted fashion, while our close partnership with external medical science colleagues allows us to provide doctors with a comprehensive range of support. Most employees have a degree in a natural science discipline, or a background in economic science, supplemented with training as a pharmaceutical representative. While this is certainly a good foundation for working in the Boehringer Ingelheim sales team, it is not a prerequisite, as all field staff receive in-depth product training, which means they are able to speak to healthcare providers in their language and be accepted as credible and reliable business partners over the long-term.

Talented planners and organisers are welcome in company administration. We offer a wide range of positions across all business areas, diverse, exciting tasks at the local and international level as well as career development opportunities. You represent Boehringer Ingelheim when dealing with visitors and external parties, and you support managers and organise events. Typical tasks include bilingual correspondence in your local language and English, planning meetings, office management, effecting payments, organising travel, creating presentations, finalising payroll statements, receiving telephone calls and evaluating surveys.

Our accounting people provide information that is crucial to the company’s financial stability and economic success. They assess, process and communicate Boehringer Ingelheim’s financial data at the local and global level, and they evaluate the company’s economic activities, reporting the results to a variety of external stakeholders as well as internal management. Key tasks include ensuring compliance with legal requirements by recording and booking all transactions, issuing complete documentation on the development of assets and liabilities, and providing the tax office and external parties (e.g. banks and shareholders) with a legally compliant evaluation in addition to the annual P/L statement. Staff works exclusively with actual postings and values, while at the same time taking historical data into account.

Our communications and PR people are the face and voice of Boehringer Ingelheim: they represent the company in its dealings with employees and the outside world and are in charge of internal and external communication. Externally, they establish and maintain relationships with Boehringer Ingelheim’s clients, the public and media across all communication channels and provide information on products and topical issues. They develop a relevant communications strategy and infrastructure and facilitate an effective flow of information, collaborative dialogue and involvement throughout the company. Day-to-day tasks include organising and running campaigns and press conferences, writing press releases and articles, arranging interviews, acting as Boehringer Ingelheim spokespersons and managing online communications and social media content. Internally, the team is responsible for communication campaigns, the local and international newspaper, newsletters and the company’s global intranet.

Our controlling department regulates the entire business operation and acts as a strategic adviser to managers. Key tasks include analysing existing steering processes and making concrete suggestions for improvements, as well as producing targeted assessments (organisation, products, markets, etc.) for decision-makers in the company on a regular basis.

Boehringer Ingelheim’s sourcing and purchasing function is responsible for ensuring the best possible purchasing conditions for the company. It also works to guarantee the timely availability of sufficient quantities of raw, auxiliary and operational materials for our research and production units, as well as products and work equipment for the wide range of specialist and functional areas.

Boehringer Ingelheim operates in a complex market environment characterized by constant political change. Government decisions on healthcare, policy and legislative initiatives increasingly impact our current and future business environment. Shaping the external environment in line with Boehringer Ingelheim’s business objectives is therefore an important element to ensure the company can continue to grow, invest in innovation and bring new therapeutic solutions to our patients.

Guided by our Leitbild, Boehringer Ingelheim’s Public Affairs function drives an open and trust-based dialogue with key external stakeholders, such as policy-makers, trade associations and non-governmental organizations. Through our representations in Berlin, Brussels and Washington, D.C., we identify and assess global political trends, position the company in important political debates, maximize opportunities for engagement and facilitate the development of appropriate strategies.

The Corporate Department Internal Consulting acts as an independent advisor developing and implementing solutions for the firm‘s strategic and operational challenges. Our methodological toolkit enables us to successfully conceptualize and finalize projects dealing with a wide range of different topics.  Our team consists of former consultants from globally leading consulting firms and colleagues with many years of experience at Boehringer Ingelheim and/or other top tier pharmaceutical companies. Internal Consulting attracts professionals from within and outside BI offering a development platform for future leaders of the firm.

The task of Boehringer Ingelheim’s internal legal department, which operates both nationally and internationally, is to understand the activities of both business partners and specialist areas, and to protect the company’s interests in a legally sound way. Our service offer in this respect includes: solution-oriented legal advice, accurate drafting of contracts to serve the interests of the parties involved, compliance management, advice and co-ordination and law enforcement in various areas The legal department works in partnership with the company’s various departments and is thereby responsible for Boehringer Ingelheim’s long-term success. Our fully qualified lawyers are specialists in their field and are supported by well-trained paralegals, assistants and clerks.

Boehringer Ingelheim’s Corporate Strategy & Development department is the navigator of BI’s strategic direction and drives corporate steering by supporting current performance goals and identifying future opportunities.

Our team refines our corporate strategy as well as monitors, supports and challenges the strategies for our Business Units. Thereby, we identify growth opportunities inside and outside our core business, drive the management of the corporate strategy and portfolio, and foster efficiency through cross-functional alignment, governance and commitment in order to develop the best strategic plan. In all projects, we promote the outside-in perspective to achieve agility and enhanced competitiveness.

We anticipate and identify trends in the healthcare system potentially affecting and transforming the traditional pharmaceutical business model. We also identify and explore potential new solutions that are “beyond the pill”, for example holistic methods, predictive models, and health measures, in order to create a business model that is future-oriented, creating new revenue streams for Boehringer Ingelheim.

The pharmaceutical industry is changing rapidly, so that new business models for profitable growth are critical for success. Our strategic development projects and the tracking of strategy implementation are carried out in close cooperation with our Business Units within the framework of an annually coordinated strategic review process.